Anzeige
Mehr »
Login
Donnerstag, 23.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2H7JK ISIN: AU000000TLX2 Ticker-Symbol: T3X 
Tradegate
21.01.20
08:02 Uhr
0,930 Euro
-0,020
-2,11 %
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
TELIX PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
TELIX PHARMACEUTICALS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,895
0,935
21:58

Aktuelle News zur TELIX PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:13TELIX PHARMACEUTICALS LIMITED: Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging36
TELIX PHARMACEUTICALS Aktie jetzt für 4€ handeln
15.01.TELIX PHARMACEUTICALS LIMITED: Appendix 3G - issue of unlisted share options4
26.12.19TELIX PHARMACEUTICALS LIMITED: NDA Clinical Briefing Package Submitted to the US FDA23
23.12.19TELIX PHARMACEUTICALS LIMITED: Zircon P3 IND submitted to US FDA11
22.12.19TELIX PHARMACEUTICALS LIMITED: TLX101 for Brain Cancer IPAX-1 Study Update5
19.12.19TELIX PHARMACEUTICALS LIMITED: Telix and Vic Cancer Centre receive Cancer Australia grant29
15.12.19TELIX PHARMACEUTICALS LIMITED: Telix and ATONCO Partner for Bladder Cancer12
24.11.19TELIX PHARMACEUTICALS LIMITED: Webcast of CEO presentation to Jefferies Conference11
20.11.19TELIX PHARMACEUTICALS LIMITED: CEO presentation to Jefferies London Healthcare Conference11
14.11.19TELIX PHARMACEUTICALS LIMITED: Change in substantial, dilution of voting due to Placement8
14.11.19TELIX PHARMACEUTICALS LIMITED: Ceasing as substantial holder - following release of escrow9
14.11.19TELIX PHARMACEUTICALS LIMITED: Appendix 3B - quotation of escrow shares, issue of options2
03.11.19TELIX PHARMACEUTICALS LIMITED: Program Update - Q3 201912
29.10.19TELIX PHARMACEUTICALS LIMITED: Telix and AusHealth Partner for Lung, Ovarian Cancer3
28.10.19TELIX PHARMACEUTICALS LIMITED: Sales Note to accompany Appendix 4C2
28.10.19TELIX PHARMACEUTICALS LIMITED: Appendix 4C - September 2019 quarter1
28.10.19TELIX PHARMACEUTICALS LIMITED: Notice of release of securities from Mandatory Escrow1
13.10.19TELIX PHARMACEUTICALS LIMITED: Telix and GE data - 68Ga supply for prostate cancer imaging6
06.10.19TELIX PHARMACEUTICALS LIMITED: David Cade appointed Chief Business Officer and Head of IR9
02.10.19TELIX PHARMACEUTICALS LIMITED: Telix to Acquire European Production Facility8
Seite:  Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1